SciClone Pharmaceuticals, Inc. (SCLN): Insiders Aren’t Crazy About It

Page 1 of 2

Is SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) an attractive investment today? The best stock pickers are becoming more confident. The number of long hedge fund bets moved up by 2 lately.

SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

According to most traders, hedge funds are perceived as underperforming, outdated financial tools of yesteryear. While there are more than 8000 funds in operation at the moment, we at Insider Monkey look at the bigwigs of this club, around 450 funds. It is widely believed that this group oversees most of the hedge fund industry’s total capital, and by keeping an eye on their best equity investments, we have figured out a few investment strategies that have historically outstripped Mr. Market. Our small-cap hedge fund strategy outpaced the S&P 500 index by 18 percentage points per year for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have topped the S&P 500 index by 24 percentage points in 7 months (see all of our picks from August).

Equally as beneficial, positive insider trading activity is a second way to break down the marketplace. As the old adage goes: there are lots of incentives for a corporate insider to downsize shares of his or her company, but just one, very simple reason why they would buy. Several empirical studies have demonstrated the valuable potential of this strategy if investors understand where to look (learn more here).

Now, it’s important to take a peek at the latest action surrounding SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN).

How have hedgies been trading SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)?

Heading into 2013, a total of 12 of the hedge funds we track were bullish in this stock, a change of 20% from the previous quarter. With hedge funds’ capital changing hands, there exists a select group of notable hedge fund managers who were boosting their stakes considerably.

Of the funds we track, AQR Capital Management, managed by Cliff Asness, holds the biggest position in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN). AQR Capital Management has a $2.3 million position in the stock, comprising less than 0.1%% of its 13F portfolio. The second largest stake is held by Millennium Management, managed by Israel Englander, which held a $2.2 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Other peers that hold long positions include Peter Algert and Kevin Coldiron’s Algert Coldiron Investors, Wilmot B. Harkey and Daniel Mack’s Nantahala Capital Management and John Overdeck and David Siegel’s Two Sigma Advisors.

As one would reasonably expect, key money managers have jumped into SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) headfirst. Nantahala Capital Management, managed by Wilmot B. Harkey and Daniel Mack, assembled the largest position in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN). Nantahala Capital Management had 0.9 million invested in the company at the end of the quarter. Neil Chriss’s Hutchin Hill Capital also made a $0.3 million investment in the stock during the quarter. The following funds were also among the new SCLN investors: Jim Simons’s Renaissance Technologies and Glenn Russell Dubin’s Highbridge Capital Management.

Insider trading activity in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

Insider purchases made by high-level executives is best served when the company in focus has experienced transactions within the past six months. Over the latest six-month time period, SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN). These stocks are Pernix Therapeutics Holdings Inc (NASDAQ:PTX), Depomed Inc (NASDAQ:DEPO), DUSA Pharmaceuticals Inc (NASDAQ:DUSA), Lannett Company, Inc. (NYSEAMEX:LCI), and Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP). All of these stocks are in the drug manufacturers – other industry and their market caps are closest to SCLN’s market cap.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

Qihoo 360 Technology Co Ltd (QIHU), Actavis plc (ACT), Yahoo! Inc. (YHOO) Among 20 Long Ideas from Sohn Canada

The 10 Laziest Countries in the World

The 10 Most Polluted Countries in the World

The 10 Most Dangerous Cities in America 2014

The Top 10 Gold Producing Countries in the World

The 10 Tallest Buildings in the World

The 10 Richest Stand Up Comedians in the World

The 10 Fattest Countries in the World

The 5 Best Summer Jobs for Teens

The 10 Most Religious Countries in the World Keeping the Faith

The 10 Most Educated Countries in the World

The 10 Most Popular Cell Phones in the World

The 10 Drunkest Countries in the World

The 10 Most Expensive Private Schools in the World

The 10 Smallest Countries in the World

Walking Dead Season 5 Spoilers You’ll Wish You Didn’t Know

The 10 Poorest Countries in the World

The 10 Greenest Countries in the World

The Top 10 Countries with the Highest Population in the World

The 10 Most Visited Countries in the World

The Top 10 Star Wars Characters in the Iconic Series

The 10 Most Expensive Android Phones in the World

5 Reasons Why The Illuminati Is Real and a Threat to Society

The 6 Scariest Halloween Costumes Ever Screamed At

The 4 Biggest Hedge Fund Managers in the World Today

The 15 Most Densely Populated Countries in the World

The 10 Biggest Tea Drinking Countries in the World

Top 6 Ways to Improve Your Checkout Process and Close Sales

The 5 Most Profitable Online Businesses You Can Start Today

The 20 Most Profitable Hospitals in the US

The 5 Most Profitable Home Businesses to Start

The 7 Teams that Will Win the Stanley Cup in 2015

The Top 10 Most Expensive Digital Cameras to Snap Stunning Shots With

The 10 Highest Quality Fast Food Restaurants In America Today

The 8 Best Halloween Decorating Ideas to Spook Up Your House

10 Marvel Women that Should Get a Movie Right Now

The 20 Best Remixes of Popular Songs that Will Make You Forget the Originals

7 Most Expensive Cities in the World

5 Least Expensive Cities in the World

10 Celebrities Who Believe In Scientology

10 High Margin Food Products to Build a Business Around

The 10 Most Expensive Clothing Stores in the United States to Get Decked Out At

The 5 Biggest Kickstarter Scams That Swindled Backers’ Donations

The 10 Most Expensive Boarding Schools In the World

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!